Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
36.61
+2.76 (8.15%)
Aug 18, 2026, 4:00 PM EDT - Market closed
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $715.7 million as of August 18, 2026. Its market cap has increased by 62.69% in one year.
Market Cap
715.70M
Enterprise Value
493.03M
1-Year Change
62.69%
Ranking
Category
Stock Price
$36.61
ChartMarket Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $715.70M, an increase of 185.56%. That is a compound annual growth rate of 62.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 715.70M | 83.32% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
| Jun 21, 2024 | 250.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 726.38M |
| Neurogene | 723.21M |
| REGENXBIO | 710.63M |
| Gyre Therapeutics | 708.31M |
| Allogene Therapeutics | 708.26M |
| 4D Molecular Therapeutics | 673.43M |
| Zevra Therapeutics | 672.22M |
| Assembly Biosciences | 670.88M |